Skip to content

Effect of guided mental imagery on motor dysfunction and balance of patients with MS

Investigating the effect of guided mental imagery on motor dysfunction and balance of patients with multiple sclerosis (MS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220614055170N1
Enrollment
60
Registered
2023-11-11
Start date
2023-12-21
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor and balance dysfunction.

Interventions

Intervention 1: Intervention group: Includes 30 eligible patients, who will perform six-minute walk, 25-foot walk, and balance tests after listening to a guided mental imagery audio file. Intervention

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Suffering from Multiple Sclerosis such as Relapsing-Remitting MS (RRMS), Primary progressive MS and Secondary progressive MS with the confirmation and diagnosis of the relevant doctor Ability to communicate in Persian Acceptable speaking ability Acceptable listening ability to clearly hear the researcher's voice and the audio file Age range between 18 and 60 years The ability to walk at least 50 meters using the patient's usual mobility aids such as canes, walkers, etc. in a six-minute walking test before the intervention Not suffering from any primary neurological, psychological, cardiac, respiratory and other diseases such as osteoarthritis or rheumatoid arthritis, etc., which affect the patient's usual movement ability. Failure to participate in a rehabilitation program or physical activity that improves and helps the disease for at least the last two months, or changing treatment in a way that affects the patient's mobility (physiotherapy or drug therapy) No use of high doses of steroids in the past month, which is defined as high-dose steroid therapy according to the following protocol: steroid use of 50 mg/day intravenously (IV) for six days, 40 mg intramuscularly (IM) for For more than 15 days, 20 mg intramuscularly for more than 30 days Not experiencing any severe clinical relapse in the disease in the past month Getting a score between 1 and 6.5 on the Extended Disability Status Scale (EDSS) means mild to moderate disability. At least one year has passed since the diagnosis of MS

Exclusion criteria

Exclusion criteria: pregnancy

Design outcomes

Primary

MeasureTime frame
The degree of motor dysfunction of the patient. Timepoint: Measuring the severity of motor dysfunction before and after the intervention. Method of measurement: 6-minute walk test and 25-foot walk test.;The degree of the patient's balance disorder. Timepoint: Measuring the severity of balance disorders before and after the intervention. Method of measurement: Berg Balance scale.

Secondary

MeasureTime frame
The degree of motor dysfunction and balance of the patient. Timepoint: Measuring the severity of motor and balance dysfunction before and after the intervention. Method of measurement: Six-minute walk test, 25-foot walk test, Berg balance scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtena Shojaie

Kerman University of Medical Sciences

shojaie.atena79@gmail.com+98 34 3252 0929

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026